WallStreetZenWallStreetZen

NASDAQ: LFMD
Lifemd Inc Stock

$7.77+0.05 (+0.65%)
Updated May 17, 2024
LFMD Price
$7.77
Fair Value Price
N/A
Market Cap
$328.59M
52 Week Low
$1.93
52 Week High
$12.88
P/E
-10.5x
P/B
-388.73x
P/S
2.47x
PEG
N/A
Dividend Yield
N/A
Revenue
$163.56M
Earnings
-$23.36M
Gross Margin
88.2%
Operating Margin
-12.3%
Profit Margin
-16.2%
Debt to Equity
-71.17
Operating Cash Flow
$17M
Beta
1.09
Next Earnings
May 29, 2024
Ex-Dividend
N/A
Next Dividend
N/A

LFMD Overview

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a telehealth platform brand that offers access to virtual medical treatment, prescription medications, patented-doctor formulated OTC products, and an FDA approved medical device for male and female hair loss, and female specific topical compounded medications for hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; LifeMD Primary Care, a personalized subscription-based virtual primary care platform that provides patients with primary care, urgent care, and chronic care needs, as well as .offers a mobile first platform that incorporates virtual consultations and treatment, prescription medications, diagnostics, and imaging; Cleared, a telehealth brand that provides personalized treatments for allergy, asthma, and immunology; and Nava MD, a female-oriented tele-dermatology and skincare brand that offers virtual medical treatment from dermatologists and other providers. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. LifeMD sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.

Zen Score

Industry Average (25)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how LFMD scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

LFMD is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
LFMD is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
LFMD's Earnings (EBIT) of -$20.12M... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more LFMD due diligence checks available for Premium users.

Be the first to know about important LFMD news, forecast changes, insider trades & much more!

LFMD News

Valuation

LFMD price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-10.5x
Industry
9.15x
Market
30.97x

LFMD price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
-388.73x
Industry
3.33x

LFMD's financial health

Profit margin

Revenue
$44.1M
Net Income
-$6.8M
Profit Margin
-17.1%
LFMD's Earnings (EBIT) of -$20.12M... subscribe to Premium to read more.
Interest Coverage Financials
LFMD's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$61.5M
Liabilities
$60.2M
Debt to equity
-71.17
LFMD's short-term liabilities ($44.68M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
LFMD's short-term assets ($44.41M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
LFMD's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
LFMD's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$5.2M
Investing
-$2.2M
Financing
-$1.0M
LFMD's operating cash flow ($16.64M)... subscribe to Premium to read more.
Debt Coverage Financials

LFMD vs Health Information Service Stocks

TickerMarket Cap1d %P/EP/B
LFMD$328.59M+0.65%-10.50x-388.73x
SPOK$319.27M+3.00%18.77x1.99x
SHCR$310.22M+9.18%-2.38x0.76x
SOPH$296.80M-1.52%-4.05x2.24x
MPLN$379.83M-1.34%-0.60x0.32x

Lifemd Stock FAQ

What is Lifemd's quote symbol?

(NASDAQ: LFMD) Lifemd trades on the NASDAQ under the ticker symbol LFMD. Lifemd stock quotes can also be displayed as NASDAQ: LFMD.

If you're new to stock investing, here's how to buy Lifemd stock.

What is the 52 week high and low for Lifemd (NASDAQ: LFMD)?

(NASDAQ: LFMD) Lifemd's 52-week high was $12.88, and its 52-week low was $1.93. It is currently -39.67% from its 52-week high and 302.59% from its 52-week low.

How much is Lifemd stock worth today?

(NASDAQ: LFMD) Lifemd currently has 42,289,990 outstanding shares. With Lifemd stock trading at $7.77 per share, the total value of Lifemd stock (market capitalization) is $328.59M.

Lifemd stock was originally listed at a price of $0.60 in Apr 1, 2013. If you had invested in Lifemd stock at $0.60, your return over the last 11 years would have been 1,195%, for an annualized return of 26.22% (not including any dividends or dividend reinvestments).

How much is Lifemd's stock price per share?

(NASDAQ: LFMD) Lifemd stock price per share is $7.77 today (as of May 17, 2024).

What is Lifemd's Market Cap?

(NASDAQ: LFMD) Lifemd's market cap is $328.59M, as of May 20, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Lifemd's market cap is calculated by multiplying LFMD's current stock price of $7.77 by LFMD's total outstanding shares of 42,289,990.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.